International patterns of childhood chronic myeloid leukemia: Comparisons between the United States and resource-restricted nations

Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries

(2013) Adam M. Mendizabal et al.   Cancer Epidemiology

Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis

(2013) Karthik R. Narayanan et al.   PEDIATRIC BLOOD & CANCER

Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia

(2011) Prasanth Ganesan et al.   AMERICAN JOURNAL OF HEMATOLOGY

How I treat childhood CML

(2011) J. R. Andolina et al.   BLOOD

Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial

(2011) Frédéric Millot et al.   JOURNAL OF CLINICAL ONCOLOGY

Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP

(2010) Panos Kanavos et al.   Globalization and Health

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

(2009) L. Noens et al.   BLOOD

Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

(2009) Kirk R. Schultz et al.   JOURNAL OF CLINICAL ONCOLOGY

Decreasing the cancer burden in developing countries: concerns and recommendations

(2008) S. KACHROO et al.   EUROPEAN JOURNAL OF CANCER CARE

Chronic myeloid leukemia in Asia

(2008) Wing Y. Au et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY